Share Name Share Symbol Market Type Share ISIN Share Description
Marlowe Plc LSE:MRL London Ordinary Share GB00BD8SLV43 ORD 50P
  Price Change % Change Share Price Shares Traded Last Trade
  -3.00 -0.39% 757.00 8,961 09:57:09
Bid Price Offer Price High Price Low Price Open Price
750.00 764.00 760.00 757.00 760.00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
General Financial 192.00 -1.60 -3.10 725
Last Trade Time Trade Type Trade Size Trade Price Currency
14:16:31 O 77 762.00 GBX

Marlowe (MRL) Latest News

More Marlowe News
Marlowe Investors    Marlowe Takeover Rumours

Marlowe (MRL) Discussions and Chat

Marlowe Forums and Chat

Date Time Title Posts
01/7/202214:11Marlowe, a leading specialist compliance services group49
04/10/202010:20everyone MUST READ!106
10/9/200810:13Medoro with Charts & News33
20/7/200715:58 Medoro Resources > recovery thread1,945
18/4/200708:19are the shares ever going to go fucking up225

Add a New Thread

Marlowe (MRL) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
View all Marlowe trades in real-time

Marlowe (MRL) Top Chat Posts

Marlowe Daily Update: Marlowe Plc is listed in the General Financial sector of the London Stock Exchange with ticker MRL. The last closing price for Marlowe was 760p.
Marlowe Plc has a 4 week average price of 740p and a 12 week average price of 740p.
The 1 year high share price is 1,082.50p while the 1 year low share price is currently 737p.
There are currently 95,838,471 shares in issue and the average daily traded volume is 278,607 shares. The market capitalisation of Marlowe Plc is £725,497,225.47.
dr biotech: Always difficult to know here whether the price drop is due to the deal or just the fundraising (or a bit of both). Seems sensible enough - if somewhat larger than normal than the typical size for MRL. They shrugged off the failed aquistion of renew, hopefully today just a temporary dip Been a largely plain sailing ride for the last 8 or so months.
1nf3rn0: A relatively large acquisition announced this morning which sounds like a very fair price and significantly earnings enhancive.Only gripe is not being able to participate in the fund raising as a PI.
km18: Marlowe is a leading and highly innovative software services firm, providing risk and compliance advice, as well as testing and inspection expertise. As a result, the corporation is involved in the provision of risk assessments, and maintenance of security systems, with the purpose of optimising engineering services while mitigating software technical issues on behalf of clients. Consequently, a wide variety of stakeholders are interested in the firm’s ability to derive capital and re-invest cash into organic growth, yielding substantial returns for investors. This evidence is supported by the equity rally of £128.1m (£266.3m-£138.2m) with respect to last year. Additionally, the software service firm was able to effectively fund its operations, since the firm’s net cashflow soared from £9.4m to £58.8m. Today, Marlowe released its financial results, where adjusted profit before tax surged 127% to £15.2m, illustrating the effectiveness of the firm’s business model and corporate investment strategy.
wad collector: Another acquisition, this time with a £50M placing @ 907p.
essential: Under the radar share this one. Scsw like it too
masurenguy: Marlowe growth plans to drive shares, says Berenberg Security systems provider Marlowe has set out ‘highly ambitious’ growth targets that Berenberg says could deliver serious upside. Analyst Calum Battersby reiterated his ‘buy’ recommendation and increased the target price from 660p to 900p. The company has announced targets over the next 3 years, including hitting £500m of revenue and £100m of earnings to be achieved ‘through a combination of 7% of organic growth per annum, 20% margins, 90% cash conversion and continuation of the group’s existing M&A strategy’, according to Battersby. ‘While clearly an aggressive target, we believe this can be achieved, given the company’s track record to date, and the scale of opportunities that already exist in its various end-markets,’ he said.
masurenguy: 28 October 2020 Marlowe plc Acquisition of Ellis Whittam (Holdings) Limited Marlowe plc, the specialist services group focused on developing companies which assure safety and regulatory compliance, announces that it has entered into a conditional agreement to acquire Ellis Whittam (Holdings) Ltd (together with its subsidiaries) for consideration of £59m on a cash-free, debt-free basis. Founded in 2004, Ellis Whittam is one of the UK's leading providers of outsourced Employment Law, HR and Health & Safety services. The company provides its services via a fixed-fee subscription model to over 3,300 organisations across the UK. It is headquartered in Chester, with offices in Glasgow and London, and employs approximately 180 staff, more than half of whom are health & safety consultants, employment lawyers and HR compliance advisors. Ellis Whittam's subscription-based advisory services help employers across the UK remain compliant with evolving employment law and health & safety legislation. The Group also announces a proposed placing to raise gross proceeds of up to £30m through the issue of up to 5,441,376 new ordinary shares of 50 pence each (the "Placing Shares") at 547p per share (the "Placing Price") to new and existing investors (the "Placing"). The Placing will be conducted by way of an accelerated bookbuild process which will be launched immediately in accordance with the terms and conditions set out in the Appendix to this Announcement. ........................................................................................................................................... . 29 October 2020 Marlowe plc Results of the Placing Further to the announcement of 28 October 2020 of the acquisition of Ellis Whittam and a proposed placing, Marlowe announces that it has successfully raised approximately £30m before expenses under the Placing, which was oversubscribed. The Placing Price of 547p per share represents a nil discount to the closing price on 28 October 2020. A total of 5,441,376 Placing Shares were placed with institutional investors, conditional on Admission. Pursuant to the Placing, the Group has raised net proceeds of approximately £29m after expenses. The issue of the Placing Shares is not subject to shareholder approval. Application has been made for the 5,441,376 Placing Shares to be admitted to trading on AIM, and it is expected that Admission will occur at 8.00 a.m. on or around 3 November 2020. Therefore, following Admission of the Placing Shares, the total number of Ordinary Shares with voting rights in the Group will be 60,266,796, which may be used by Shareholders as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change to their interest in, the Group under the FCA's Disclosure Guidance and Transparency Rules.
dr biotech: Small company share watch. It’s a decent journal.
dr biotech: I bought these on the back of a share tip sheet. Its interesting to see the number of trades today so far is 34. Last week there were typically between 5-15 trades a day, gives an idea how many of us are reading and following this publication. I guess you'd have to look after a few days for a real figure. But I did notice this was marked up on opening to make sure we all paid a few quid extra.
masurenguy: Thread relinquished Active Charts and Newsfeed remain available. Completely exited during w/c 2/8/21 so no further updates will be made to this thread.
Marlowe share price data is direct from the London Stock Exchange
ADVFN Advertorial
Your Recent History
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P: V: D:20220706 13:45:32